Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Judith WellensMatthew EdmansUri ObolskiColleen Gc McGregorPeter SimmondsMarc TurnerLisa JarvisDonal SkellySusanna DunachieEleanor BarnesDavid W EyreJean-Frederic ColombelSerre-Yu WongPaul KlenermanJames O LindsayJack SatsangiCraig P ThompsonPublished in: Gut (2021)